Bluebird Bio Company
bluebird bio, Inc., based in Cambridge, Massachusetts, is a biotechnology company that develops gene therapies for severe genetic disorders and cancer
Total Funding:
409000000 USD
Investor Type:
N/A
Technology:
Genetic Test & Molecular Diagnostics
Investment Stage:
N/A
Last Funding Type:
Post-IPO Equity
Estimated Revenue:
$10M to $50M
Founded Date:
01.01.1993
Industry:
Stem Cell Exhaustion
Employee Number:
501-1000
Last Funding Date:
2016-12-07
Funding Status:
IPO
Number Of Exists:
N/A
Headquarters:
United Kingdom
Investors Number:
13